Association of 5α-Reductase Inhibitors With Depression and Suicide: A Mini Systematic Review and Meta-Analysis

    May 2024 in “ European urology focus ”
    Alessandro Uleri, Jean Nicolas Cornu, Andrea Gobbo … Michael Baboudjian
    Studysummary In this systematic review and meta-analysis, the authors found no statistically significant association between the use of 5α-reductase inhibitors and the risk of depression or suicide among over two million studied patients.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on eu-focus.europeanurology.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide JAMA network open · 2022
    2. Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride JAMA Dermatology · 2020
    3. Association of Suicidality and Depression With 5α-Reductase Inhibitors JAMA Internal Medicine · 2017